1. Lung Cancer. 2013 Aug;81(2):308-10. doi: 10.1016/j.lungcan.2013.05.003. Epub 
2013 May 31.

A case of lung adenocarcinoma harboring exon 19 EGFR deletion and EML4-ALK 
fusion gene.

Chen X(1), Zhang J, Hu Q, Li X, Zhou C.

Author information:
(1)Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji 
University School of Medicine Tongji University Medical School Cancer Institute 
Tongji University, No 507 Zhengmin Road, Shanghai 200433, People's Republic of 
China.

We report a man with advanced adenocarcinoma who harboring exon 19 
(E746-A750del) epidermal growth factor receptor (EGFR) deletion and echinoderm 
microtubule-associated protein like 4-anaplastic lymphoma kinase (EML4-ALK) gene 
translocation in the re-biospy specimen. The patient was treated with erlotinib 
with a stable disease but progressed slowly, while crizotinib showed a complete 
response.

Copyright Â© 2013 Elsevier Ireland Ltd. All rights reserved.

DOI: 10.1016/j.lungcan.2013.05.003
PMID: 23731739 [Indexed for MEDLINE]